Literature DB >> 19874920

Cyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitro.

Cesar A B Nava-Ortiz1, Guillermina Burillo, Angel Concheiro, Emilio Bucio, Nele Matthijs, Hans Nelis, Tom Coenye, Carmen Alvarez-Lorenzo.   

Abstract

Polyethylene (PE) and polypropylene (PP) were functionalized at their surfaces with cyclodextrins (CDs) in order to prevent the adhesion and proliferation of Candida albicans on medical devices made from these polymers. The surface functionalization involved the grafting of glycidyl methacrylate (GMA) after oxidative gamma-ray pre-irradiation, followed by the attachment of beta-CD and HP-beta-CD to PE-g-GMA and PP-g-GMA surfaces. The yield of CD functionalization directly depended on the amount of GMA grafted. The presence of CDs on the surface of the polymers did not compromise their cell compatibility, but remarkably changed their protein adsorption profile. In contrast to unmodified PE and PP that adsorb significant amounts of fibrinogen ( approximately 0.047 mg cm(-2)) but not albumin, the CD-modified polyethers promoted the adsorption of albumin (between 0.015 and 0.155 mg cm(-2)) and reduced the adsorption of fibrinogen. Furthermore, functionalization with CDs provided PE and PP with the capability to incorporate the anti-fungal drug miconazole (up to 0.27 mg cm(-2)), leading to reduced biofilm formation by C. albicans in an in vitro biofilm model system. Overall, the results of the work indicate that the novel approach for functionalization of PE and PP is potentially useful to reduce the likelihood of foreign body-related infections. Copyright 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874920     DOI: 10.1016/j.actbio.2009.10.039

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  6 in total

Review 1.  Emerging technologies for long-term antimicrobial device coatings: advantages and limitations.

Authors:  Erika L Cyphert; Horst A von Recum
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 2.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

3.  Candida biofilms and the host: models and new concepts for eradication.

Authors:  Hélène Tournu; Patrick Van Dijck
Journal:  Int J Microbiol       Date:  2011-11-14

Review 4.  Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices.

Authors:  Mohankandhasamy Ramasamy; Jintae Lee
Journal:  Biomed Res Int       Date:  2016-10-31       Impact factor: 3.411

Review 5.  In vitro and ex vivo systems at the forefront of infection modeling and drug discovery.

Authors:  Di Shi; Gujie Mi; Mian Wang; Thomas J Webster
Journal:  Biomaterials       Date:  2018-10-24       Impact factor: 12.479

Review 6.  Recent advances in nanotechnology for eradicating bacterial biofilm.

Authors:  Célia Sahli; Sergio E Moya; John S Lomas; Christine Gravier-Pelletier; Romain Briandet; Miryana Hémadi
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.